[1]
|
Grant, D.M. (1991) Detoxification pathways in the liver. Journal of Inherited Metabolic Disease, 14, 421-430.
doi:10.1007/BF01797915
|
[2]
|
Liska, D.J. (1998) The detoxification enzyme systems. Alternative Medicine Review, 3, 187-198.
|
[3]
|
Liska, D., Lyon, M. and Jones, D.S. (2006) Detoxification and biotransformation imbalances. Explore, 2, 122-140.
doi:10.1208/aapsj0903031
|
[4]
|
Lampe, J.W. (2007) Diet, genetic polymorphisms, detoxification, and health risks. Alternative Therapies in Health and Medicine, 13, S108-111.
|
[5]
|
Newman, M. (2004) Urinary organic acid analysis: A powerful clinical tool. Townsend Letters for Doctors and Patients, 255, 80-90.
|
[6]
|
Vangala, S. and Tonelli, A. (2007) Biomarkers, metabonomics, and drug development: Can inborn errors of metabolism help in understanding drug toxicity? The AAPS Journal, 9, E284-297.
doi:10.1208/aapsj0903031
|
[7]
|
Zhang, Q., Jingbo, P., Woods, C.G. and Andersen, M.E. (2009) Phase I to II cross-induction of xenobiotic metabolizing enzymes: A feedforward control mechanism for potential hormetic responses. Toxicology and Applied Pharmacology, 237, 345-356.
doi:10.1016/j.taap.2009.04.005
|
[8]
|
Turrens, J.F. (2003) Mitochondrial formation of reactive oxygen species. The Journal of Pysiology, 552, 335-344.
doi:10.1113/jphysiol.2003.049478
|
[9]
|
Cutler, R.G., Plummer, J., Chowdhury, K. and Heward, C. (2005) Oxidative stress profiling. Part II. Theory, technology, and practice. Annals of the New York Academy of Sciences, 1055, 136-158.
doi:10.1196/annals.1323.031
|
[10]
|
Townsend, D.M., Tew, K.D. and Tapiero, H. (2003) The importance of glutathione in human disease. Biomedicine & Pharmacotherapy, 57, 145-155.
doi:10.1016/S0753-3322(03)00043-X
|
[11]
|
Kidd, P.M. (1997) Glutathione: Systemic protectant against oxidative and free radical damage. Alternative Medicine Review, 2, 155-176.
|
[12]
|
Pamplona, R. (2008) Membrane phospholipids, lipoxidative damage and molecular integrity: A causal role in aging and longevity. Biochimica et Biophysica Acta, 1777, 1249-1262. doi:10.1016/j.bbabio.2008.07.003
|
[13]
|
Catala, A. (2009) Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chemistry and Physics of Lipids, 157, 1-11.
doi:10.1016/j.chemphyslip.2008.09.004
|
[14]
|
Sim, K. G.; Hammond, J. and Wilcken, B. (2002) Strategies for the diagnosis of mitochondrial fatty acid β-oxidation disorders. Clinica Chimica Acta, 323, 37-58.
doi:10.1016/S0009-8981(02)00182-1
|
[15]
|
Vockley, J.; Whiteman, D. A. H. (2002) Defects of mitochondrial β-oxidation: A growing group of disorders. Neuromuscular Disorders, 12, 235-246.
doi:10.1016/S0960-8966(01)00308-X
|
[16]
|
Kompare, M. and Rizzo, W.B. (2008) Mitochondrial fatty-acid oxidation disorders. Seminars in Pediatric Neurology, 15, 140-149.
doi:10.1016/j.spen.2008.05.008
|
[17]
|
Fromenty, B. and Pessayre, D. (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacology & Therapeutics, 67, 101-154.
doi:10.1016/0163-7258(95)00012-6
|
[18]
|
Cooper, T. G.; Beevers, H. (1969) β-Oxidation in glyoxysomes from castor bean endosperm. Journal of Biological Chemistry, 244, 3514-3520.
|
[19]
|
Inestrosa, N.C., Bronfman, M. and Leighton, F. (1979) Detection of peroxisomal fatty acyl-coenzyme A oxidase activity. Biochemical Journal, 182, 779-788.
|
[20]
|
Foerster, E., Fahrenkemper, T., Rabe, U., Graf, P. and Sies, H. (1981) Peroxisomal fatty acid oxidation as detected by H2O2 production in intact perfused rat liver. Biochemical Journal, 196, 705-712.
|
[21]
|
Johnson, E.F., Palmer, C.N.A., Griffin, K.J. and Hsu, M. (1996) Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. The Journal of the Federation of American Societies for Experimental Biology, 10, 1241-1248.
|
[22]
|
Hardwick, J.P. (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic disease. Biochemical Pharmacology, 75, 2263- 2275. doi:10.1016/j.bcp.2008.03.004
|
[23]
|
Hayashi, S., Yasui, H. and Sakurai, H. (2005) Essential role of singlet oxygen species in cytochrome P450-dependant substrate oxygenation by rat liver microsomes. Drug Metabolism and Pharmacokinetics, 20, 14-23. doi:10.2133/dmpk.20.14
|
[24]
|
Schuck, P.F.; Ferreira, G.C., Moura, A.P., Busanello, E.N. B., Tonin, A.M., Dutra-Filho, C.S. and Wajner, M. (2009) Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain. Neurochemistry International, 54, 519-525.
doi:10.1016/j.neuint.2009.02.009
|
[25]
|
Schuck, P.F., Ferreira, G.C., Tonin, A.M., Viegas, C.M., Busanello, E.N.B., Moura, A.P., Zanatta, A., Klamt, F. and Wajner, M. (2009) Evidence that the major metabolites accumulating in medium-chain acyl-CoA dehydrogenase deficiency disturb mitochondrial energy homeostasis in rat brain. Brain Research, 1296, 117-126.
doi:10.1016/j.brainres.2009.08.053
|
[26]
|
Mitchell, G.A., Gauthier, N., Lesimple, A., Wang, S.P., Mamer, O. and Qureshi, I. (2008) Hereditary and acquired diseases of acyl-coenzyme a metabolism. Molecular Genetics and Metabolism, 94, 4-15.
doi:10.1016/j.ymgme.2007.12.005
|